Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1b MAD Study of PA1010 in Chinese Patients with Chronic Hepatitis B
NCT05019040Phase 2Completed
- Sponsor
- Apeloa
- Start
- Sep 2021
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of PA1010 in Chronic Hepatitis B (CHB), sponsored by Apeloa. Started Sep 2021; status: completed.
02
Drugs
PA1010
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT05019040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05019040.